Nootropil, 1200 mg 20 pcs

Notropil improves cognitive (learning) processes such as learning ability, memory, attention, and mental performance.

Notropil affects CNS in different ways: it changes the speed of excitation distribution in the brain, improves metabolic processes in nerve cells, improves microcirculation by affecting the rheological characteristics of blood without causing vasodilatation.

It improves connections between cerebral hemispheres and synaptic conduction in neocortical structures, increases mental performance, improves cerebral blood flow.

Inhibits platelet aggregation and restores erythrocyte membrane elasticity, reduces erythrocyte adhesion. At a dose of 9.6 g it decreases the level of fibrinogen and Willebrand factors by 30%-40% and prolongs the bleeding time.

Notropil has a protective and restorative effect in disorders of brain function due to hypoxia and intoxication.

Limits the severity and duration of vestibular nystagmus.

Indications

Treatment of the consequences of ischemic stroke, such as speech disorders, emotional disturbances, to increase motor and mental activity;
symptomatic treatment of psychoorganic syndrome (including in elderly patients with memory loss, dizziness, decreased ability to concentrate, mood changes, behavior disorder, gait disturbance, as well as in patients with Alzheimer’s disease and senile dementia of the Alzheimer’s type);
for the treatment of withdrawal syndrome and psychoorganic syndrome in chronic alcoholism;
comatose states (and during the recovery period), incl. after brain injuries and intoxications;
for the treatment of dizziness and related balance disorders (except for cases of dizziness of vasomotor and psychogenic origin);
as part of complex therapy for learning disabilities in children with psychoorganic syndrome;
treatment of cortical myoclonus (both as monotherapy and as part of combination therapy);
sickle cell anemia (as part of combination therapy).

Pharmacological effect

Nootropil improves cognitive (cognitive) processes, such as learning ability, memory, attention, as well as mental performance.

Nootropil affects the central nervous system in various ways: it changes the speed of propagation of excitation in the brain, improves metabolic processes in nerve cells, improves microcirculation, affecting the rheological characteristics of the blood and without causing a vasodilator effect.

Improves connections between the cerebral hemispheres and synaptic conduction in neocortical structures, increases mental performance, and improves cerebral blood flow.

Inhibits platelet aggregation and restores the elasticity of the erythrocyte membrane, reduces the adhesion of erythrocytes. At a dose of 9.6 g, it reduces the level of fibrinogen and von Willibrand factors by 30%-40% and prolongs bleeding time.

Nootropil has a protective and restorative effect in cases of impaired brain function due to hypoxia and intoxication.

Reduces the severity and duration of vestibular nystagmus.

Special instructions

Caution should be exercised when prescribing the drug to patients with impaired hemostasis, during major surgery, or to patients with symptoms of severe bleeding.

When treating patients with cortical myoclonus, abrupt discontinuation of therapy should be avoided, because this may cause the attacks to recur.

During long-term therapy in elderly patients, regular monitoring of renal function indicators is recommended; if necessary, dose adjustment is carried out depending on the results of a creatinine clearance study.

Nootropil penetrates through the filter membranes of hemodialysis machines.

Impact on the ability to drive vehicles and operate machinery

Taking into account possible undesirable effects, the patient should be careful when operating machinery and driving a car.

Active ingredient

Piracetam

Composition

Active ingredient:

piracetam 800 or 1200 mg;

Excipients:

macrogol 6000,

colloidal silicon anhydride (Aerosil R972),

magnesium stearate,

sodium croscarmellose,

titanium dioxide (E171),

macrogol 400,

hydroxypropyl methylcellulose

Contraindications

Children under 1 year of age;
hemorrhagic stroke;
severe renal dysfunction (creatinine clearance less than 20 ml/min);
hypersensitivity to piracetam, pyrrolidone derivatives and other components of the drug.

Side Effects

From the side of the central nervous system: hyperkinesia (1.72%), nervousness (1.13%), drowsiness (0.96%), depression (0.83%), asthenia (0.23%). These side effects occur more often in elderly patients receiving the drug at a dose of more than 2.4 g/day.

In some cases – dizziness, headache, ataxia, imbalance, exacerbation of epilepsy, insomnia, confusion, agitation, anxiety, hallucinations, increased sexuality.

From the metabolic side: increase in body weight (1.29%).

From the digestive system: in some cases – nausea, vomiting, diarrhea, abdominal pain.

Dermatological reactions: dermatitis, itching, rash, swelling.

Storage conditions

The drug should be stored in a dry place at a temperature not exceeding 25°C.

Shelf life

4 years

Manufacturer

UCB Farma, Belgium